Considering its nature, Lp-PLA2 could be a static biomarker of AD risk, essentially reflecting predisposition and/or underlying physiopathological conditions of AD, such as low-grade inflammation, atherosclerosis, and OxS. The gene discussed is PLA2G7; the disease is atherosclerosis.